Literature DB >> 22933865

Management of arthritis in patients with inflammatory bowel disease.

Timothy R Orchard1.   

Abstract

Entities:  

Year:  2012        PMID： 22933865      PMCID： PMC3424429     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease.

Authors:  T R Orchard; S Thiyagaraja; K I Welsh; B P Wordsworth; J S Hill Gaston; D P Jewell
Journal:  Gastroenterology       Date:  2000-02       Impact factor: 22.682

2.  Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms.

Authors:  F Van den Bosch; E Kruithof; M De Vos; F De Keyser; H Mielants
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

Review 3.  Rheumatic manifestations of inflammatory bowel disease.

Authors:  Tatiana Sofía Rodríguez-Reyna; Cynthia Martínez-Reyes; Jesús Kazúo Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

4.  An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.

Authors:  W Reinisch; W Miehsler; C Dejaco; M Harrer; T Waldhoer; C Lichtenberger; H Vogelsang
Journal:  Aliment Pharmacol Ther       Date:  2003-06-01       Impact factor: 8.171

Review 5.  Joint involvement associated with inflammatory bowel disease.

Authors:  M De Vos
Journal:  Dig Dis       Date:  2009-11-04       Impact factor: 2.404

6.  The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease.

Authors:  T R Orchard; H Holt; L Bradbury; J Hammersma; E McNally; D P Jewell; B P Wordsworth
Journal:  Aliment Pharmacol Ther       Date:  2008-10-09       Impact factor: 8.171
  6 in total
  3 in total

1.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

Review 2.  Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Authors:  Hiroshi Nakase; Motoi Uchino; Shinichiro Shinzaki; Minoru Matsuura; Katsuyoshi Matsuoka; Taku Kobayashi; Masayuki Saruta; Fumihito Hirai; Keisuke Hata; Sakiko Hiraoka; Motohiro Esaki; Ken Sugimoto; Toshimitsu Fuji; Kenji Watanabe; Shiro Nakamura; Nagamu Inoue; Toshiyuki Itoh; Makoto Naganuma; Tadakazu Hisamatsu; Mamoru Watanabe; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-04-22       Impact factor: 7.527

3.  Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach.

Authors:  Anukriti Verma; Shivani Sharda; Bhawna Rathi; Pallavi Somvanshi; Bimlesh Dhar Pandey
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.